Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Sell
1
GRDN Quote, Financials, Valuation and Earnings
Last price:
$19.45
Seasonality move
:
--
Day range:
$19.45 - $20.17
52-week range:
$14.16 - $25.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.04x
P/B ratio:
9.82x
Volume:
94.4K
Avg. volume:
229.9K
1-year change:
--
Market cap:
$1.3B
Revenue:
$1B
EPS (TTM):
-$1.43
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GRDN
Guardian Pharmacy Services
|
$320.5M | $0.20 | 14.04% | -49.94% | -- |
|
BKD
Brookdale Senior Living
|
$781.5M | -$0.24 | 3.6% | -40.6% | $7.38 |
|
ENSG
Ensign Group
|
$1.1B | $1.48 | 15.2% | 299.72% | $169.50 |
|
LFST
LifeStance Health Group
|
$313.6M | -$0.00 | 11.29% | -95.93% | $8.70 |
|
PACS
PACS Group
|
$1.1B | $0.40 | 12.05% | 19.71% | $34.83 |
|
PNTG
Pennant Group
|
$185.8M | $0.24 | 26.63% | 76.79% | $38.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GRDN
Guardian Pharmacy Services
|
$19.79 | -- | $1.3B | -- | $0.00 | 0% | 1.04x |
|
BKD
Brookdale Senior Living
|
$5.13 | $7.38 | $1B | -- | $0.00 | 0% | 0.38x |
|
ENSG
Ensign Group
|
$132.50 | $169.50 | $7.6B | 32.16x | $0.06 | 0.18% | 1.87x |
|
LFST
LifeStance Health Group
|
$7.84 | $8.70 | $3B | -- | $0.00 | 0% | 2.45x |
|
PACS
PACS Group
|
$13.35 | $34.83 | $2.1B | 20.01x | $0.00 | 0% | 0.59x |
|
PNTG
Pennant Group
|
$26.54 | $38.25 | $911.6M | 39.03x | $0.00 | 0% | 1.25x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GRDN
Guardian Pharmacy Services
|
25.69% | 0.000 | 4.12% | 0.81x |
|
BKD
Brookdale Senior Living
|
92.68% | 0.381 | 273.65% | 0.58x |
|
ENSG
Ensign Group
|
7.74% | 0.599 | 1.82% | 1.46x |
|
LFST
LifeStance Health Group
|
16.26% | 1.203 | 10.42% | 1.20x |
|
PACS
PACS Group
|
46.18% | 0.000 | 10.9% | 1.57x |
|
PNTG
Pennant Group
|
39.13% | 1.502 | 9.9% | 0.98x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GRDN
Guardian Pharmacy Services
|
$60.9M | -$104.6M | -90.49% | -109.2% | -33.28% | -- |
|
BKD
Brookdale Senior Living
|
$198.1M | $11.2M | -5.08% | -54.76% | 1.17% | $11.5M |
|
ENSG
Ensign Group
|
$167M | $89.3M | 13.79% | 15.07% | 9.31% | $89M |
|
LFST
LifeStance Health Group
|
$100.4M | $47K | -5.57% | -6.64% | 0.01% | $17.7M |
|
PACS
PACS Group
|
$153.9M | $710K | -- | -- | -0.33% | -$76.7M |
|
PNTG
Pennant Group
|
$25.3M | $10.8M | 8.8% | 13.06% | 6.03% | $6.8M |
Guardian Pharmacy Services vs. Competitors
-
Which has Higher Returns GRDN or BKD?
Brookdale Senior Living has a net margin of -38.8% compared to Guardian Pharmacy Services's net margin of -6.47%. Guardian Pharmacy Services's return on equity of -109.2% beat Brookdale Senior Living's return on equity of -54.76%.
Company Gross Margin Earnings Per Share Invested Capital GRDNGuardian Pharmacy Services19.36% -$2.00 $178M BKDBrookdale Senior Living25.27% -$0.22 $4B -
What do Analysts Say About GRDN or BKD?
Guardian Pharmacy Services has a consensus price target of --, signalling upside risk potential of 21.27%. On the other hand Brookdale Senior Living has an analysts' consensus of $7.38 which suggests that it could grow by 43.76%. Given that Brookdale Senior Living has higher upside potential than Guardian Pharmacy Services, analysts believe Brookdale Senior Living is more attractive than Guardian Pharmacy Services.
Company Buy Ratings Hold Ratings Sell Ratings GRDNGuardian Pharmacy Services0 0 0 BKDBrookdale Senior Living2 0 0 -
Is GRDN or BKD More Risky?
Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Brookdale Senior Living has a beta of 1.306, suggesting its more volatile than the S&P 500 by 30.623%.
-
Which is a Better Dividend Stock GRDN or BKD?
Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brookdale Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services pays 160.75% of its earnings as a dividend. Brookdale Senior Living pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRDN or BKD?
Guardian Pharmacy Services quarterly revenues are $314.4M, which are smaller than Brookdale Senior Living quarterly revenues of $784.2M. Guardian Pharmacy Services's net income of -$122M is lower than Brookdale Senior Living's net income of -$50.7M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while Brookdale Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 1.04x versus 0.38x for Brookdale Senior Living. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRDNGuardian Pharmacy Services1.04x -- $314.4M -$122M BKDBrookdale Senior Living0.38x -- $784.2M -$50.7M
-
Which has Higher Returns GRDN or ENSG?
Ensign Group has a net margin of -38.8% compared to Guardian Pharmacy Services's net margin of 7.25%. Guardian Pharmacy Services's return on equity of -109.2% beat Ensign Group's return on equity of 15.07%.
Company Gross Margin Earnings Per Share Invested Capital GRDNGuardian Pharmacy Services19.36% -$2.00 $178M ENSGEnsign Group15.44% $1.34 $1.9B -
What do Analysts Say About GRDN or ENSG?
Guardian Pharmacy Services has a consensus price target of --, signalling upside risk potential of 21.27%. On the other hand Ensign Group has an analysts' consensus of $169.50 which suggests that it could grow by 27.93%. Given that Ensign Group has higher upside potential than Guardian Pharmacy Services, analysts believe Ensign Group is more attractive than Guardian Pharmacy Services.
Company Buy Ratings Hold Ratings Sell Ratings GRDNGuardian Pharmacy Services0 0 0 ENSGEnsign Group4 1 0 -
Is GRDN or ENSG More Risky?
Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ensign Group has a beta of 0.935, suggesting its less volatile than the S&P 500 by 6.508%.
-
Which is a Better Dividend Stock GRDN or ENSG?
Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ensign Group offers a yield of 0.18% to investors and pays a quarterly dividend of $0.06 per share. Guardian Pharmacy Services pays 160.75% of its earnings as a dividend. Ensign Group pays out 6.16% of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Guardian Pharmacy Services's is not.
-
Which has Better Financial Ratios GRDN or ENSG?
Guardian Pharmacy Services quarterly revenues are $314.4M, which are smaller than Ensign Group quarterly revenues of $1.1B. Guardian Pharmacy Services's net income of -$122M is lower than Ensign Group's net income of $78.4M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while Ensign Group's PE ratio is 32.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 1.04x versus 1.87x for Ensign Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRDNGuardian Pharmacy Services1.04x -- $314.4M -$122M ENSGEnsign Group1.87x 32.16x $1.1B $78.4M
-
Which has Higher Returns GRDN or LFST?
LifeStance Health Group has a net margin of -38.8% compared to Guardian Pharmacy Services's net margin of -1.91%. Guardian Pharmacy Services's return on equity of -109.2% beat LifeStance Health Group's return on equity of -6.64%.
Company Gross Margin Earnings Per Share Invested Capital GRDNGuardian Pharmacy Services19.36% -$2.00 $178M LFSTLifeStance Health Group32.12% -$0.02 $1.7B -
What do Analysts Say About GRDN or LFST?
Guardian Pharmacy Services has a consensus price target of --, signalling upside risk potential of 21.27%. On the other hand LifeStance Health Group has an analysts' consensus of $8.70 which suggests that it could grow by 10.97%. Given that Guardian Pharmacy Services has higher upside potential than LifeStance Health Group, analysts believe Guardian Pharmacy Services is more attractive than LifeStance Health Group.
Company Buy Ratings Hold Ratings Sell Ratings GRDNGuardian Pharmacy Services0 0 0 LFSTLifeStance Health Group2 2 0 -
Is GRDN or LFST More Risky?
Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LifeStance Health Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GRDN or LFST?
Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LifeStance Health Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services pays 160.75% of its earnings as a dividend. LifeStance Health Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRDN or LFST?
Guardian Pharmacy Services quarterly revenues are $314.4M, which are larger than LifeStance Health Group quarterly revenues of $312.7M. Guardian Pharmacy Services's net income of -$122M is lower than LifeStance Health Group's net income of -$6M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while LifeStance Health Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 1.04x versus 2.45x for LifeStance Health Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRDNGuardian Pharmacy Services1.04x -- $314.4M -$122M LFSTLifeStance Health Group2.45x -- $312.7M -$6M
-
Which has Higher Returns GRDN or PACS?
PACS Group has a net margin of -38.8% compared to Guardian Pharmacy Services's net margin of -1.11%. Guardian Pharmacy Services's return on equity of -109.2% beat PACS Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRDNGuardian Pharmacy Services19.36% -$2.00 $178M PACSPACS Group15.67% -$0.07 $1.1B -
What do Analysts Say About GRDN or PACS?
Guardian Pharmacy Services has a consensus price target of --, signalling upside risk potential of 21.27%. On the other hand PACS Group has an analysts' consensus of $34.83 which suggests that it could grow by 160.92%. Given that PACS Group has higher upside potential than Guardian Pharmacy Services, analysts believe PACS Group is more attractive than Guardian Pharmacy Services.
Company Buy Ratings Hold Ratings Sell Ratings GRDNGuardian Pharmacy Services0 0 0 PACSPACS Group4 1 0 -
Is GRDN or PACS More Risky?
Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison PACS Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GRDN or PACS?
Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACS Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services pays 160.75% of its earnings as a dividend. PACS Group pays out 71.23% of its earnings as a dividend. PACS Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Guardian Pharmacy Services's is not.
-
Which has Better Financial Ratios GRDN or PACS?
Guardian Pharmacy Services quarterly revenues are $314.4M, which are smaller than PACS Group quarterly revenues of $981.8M. Guardian Pharmacy Services's net income of -$122M is lower than PACS Group's net income of -$10.9M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while PACS Group's PE ratio is 20.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 1.04x versus 0.59x for PACS Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRDNGuardian Pharmacy Services1.04x -- $314.4M -$122M PACSPACS Group0.59x 20.01x $981.8M -$10.9M
-
Which has Higher Returns GRDN or PNTG?
Pennant Group has a net margin of -38.8% compared to Guardian Pharmacy Services's net margin of 3.43%. Guardian Pharmacy Services's return on equity of -109.2% beat Pennant Group's return on equity of 13.06%.
Company Gross Margin Earnings Per Share Invested Capital GRDNGuardian Pharmacy Services19.36% -$2.00 $178M PNTGPennant Group14.01% $0.20 $296.2M -
What do Analysts Say About GRDN or PNTG?
Guardian Pharmacy Services has a consensus price target of --, signalling upside risk potential of 21.27%. On the other hand Pennant Group has an analysts' consensus of $38.25 which suggests that it could grow by 40.17%. Given that Pennant Group has higher upside potential than Guardian Pharmacy Services, analysts believe Pennant Group is more attractive than Guardian Pharmacy Services.
Company Buy Ratings Hold Ratings Sell Ratings GRDNGuardian Pharmacy Services0 0 0 PNTGPennant Group2 1 0 -
Is GRDN or PNTG More Risky?
Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pennant Group has a beta of 1.935, suggesting its more volatile than the S&P 500 by 93.465%.
-
Which is a Better Dividend Stock GRDN or PNTG?
Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pennant Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services pays 160.75% of its earnings as a dividend. Pennant Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRDN or PNTG?
Guardian Pharmacy Services quarterly revenues are $314.4M, which are larger than Pennant Group quarterly revenues of $180.7M. Guardian Pharmacy Services's net income of -$122M is lower than Pennant Group's net income of $6.2M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while Pennant Group's PE ratio is 39.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 1.04x versus 1.25x for Pennant Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRDNGuardian Pharmacy Services1.04x -- $314.4M -$122M PNTGPennant Group1.25x 39.03x $180.7M $6.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
70
OKLO alert for Jan 6
Oklo [OKLO] is up 10.09% over the past day.
Sell
39
DOGZ alert for Jan 6
Dogness (International) [DOGZ] is up 3.39% over the past day.
Buy
66
DMRC alert for Jan 6
Digimarc [DMRC] is up 1.05% over the past day.
